AI Workflow for Generating Synthetic DICOM Scans for Regulatory Submissions

For MedTech companies, the bottleneck in regulatory submissions isn't algorithm innovation—it's assembling the volume and variety of annotated, privacy-compliant DICOM scans required to demonstrate efficacy. This custom workflow automates the generation of statistically realistic synthetic scans, complete with pathologies and metadata, directly formatted for FDA eSTAR or 510(k) packages. It eliminates the manual, months-long process of data procurement, de-identification, and annotation, compressing submission timelines from quarters to weeks while fully preserving patient PHI.

Implementation requires orchestrating conditional GANs or diffusion models with a clinical knowledge graph to enforce anatomical and pathological plausibility. An automated validation agent scores outputs against real-world statistical distributions and DICOM standards, routing failures to a human-in-the-loop review console. The final architecture integrates with submission platforms like Veeva Vault or Oracle Argus, embedding comprehensive audit trails for regulatory defensibility. This turns synthetic data from a research tool into a governed, operational asset for de-risking the regulatory pathway.

This architecture automates the high-volume generation of statistically realistic, annotated DICOM scans required to demonstrate algorithm efficacy to the FDA or EMA. It replaces the manual, privacy-constrained process of curating real patient scans, directly reducing submission preparation from months to weeks. The operational upside comes from parallelized synthetic data creation, automated quality gates, and seamless integration with submission assembly platforms, enabling faster regulatory pathways and more robust validation.

Implementation integrates with existing clinical data warehouses to extract statistical profiles, using conditional generative models (e.g., GANs, diffusion) controlled by agentic logic. The orchestrator, built on LangGraph, manages specialized agents for anatomy, pathology, and DICOM header generation, ensuring compliance with DICOM standards and submission-specific annotation rules. Critical controls include automated fidelity scoring against real-world distributions, mandatory human review for low-confidence slices, and immutable audit logging for regulatory traceability throughout the pipeline.

This workflow automates the creation of statistically valid, annotated synthetic DICOMs to meet the volume and variety requirements for regulatory algorithm validation. It eliminates the multi-month bottleneck of procuring and de-identifying real patient scans, directly accelerating time-to-market for AI/ML-based medical devices. The operational upside comes from compressing the data preparation phase of a submission from quarters to weeks, while maintaining full control over pathological findings and metadata required for demonstration of efficacy.

Implementation follows a phased delivery: Phase 1 establishes the core generative pipeline integrated with a PACS sandbox. Phase 2 adds the multi-agent validation layer and integration with submission assembly platforms like Veeva Vault or Lorenz docuBridge. Phase 3 implements full audit logging, governance controls, and automated report generation for regulatory auditors. Critical constraints include managing model drift to prevent fidelity decay, establishing radiologist-in-the-loop gates for novel findings, and ensuring synthetic data is never commingled with real PHI in storage or training.

The workflow directly addresses the high cost and delay of assembling large, annotated imaging datasets for regulatory packages. By generating statistically realistic synthetic DICOMs with embedded pathologies and correct metadata, MedTech teams can demonstrate algorithm efficacy across diverse patient anatomies and disease presentations without exposing PHI. The operational upside is a 6-12 month acceleration in the regulatory pathway, reducing time-to-market and enabling more robust validation than limited real-world data allows. Implementation requires integration with source PACS for style transfer and submission assembly platforms like Veeva Vault.

Governance is architected into the pipeline. The Fidelity & Privacy Validator agent runs automated checks against statistical similarity metrics (KS tests, SSIM) and differential privacy bounds, flagging outliers. All scans must pass through a mandatory Medical & Compliance Review Gate staffed by qualified personnel before release to the submission library. This human-in-the-loop control, integrated with a system like ServiceNow for ticket routing, ensures clinical plausibility and creates an auditable decision trail for regulators. Rollout is sequenced, starting with a single modality and body region, with monitoring for pipeline drift and validation score degradation.